Why the study?
Because severe cases of acute pancreatitis carry a substantial risk of death, early assessment of severity is critical, prompting an evaluation of the predictive significance of the CRP to albumin ratio.
Does the CRP/albumin ratio at admission predict severity and mortality in patients with acute pancreatitis?
Population
2244 patients with acute pancreatitis across six trials
Comparison
CRP/alb ratio at admission compared across severity groups and survival status
Design
Systematic review and meta-analysis
Key result
Upon admission, the C-reactive protein-to-albumin ratio was significantly higher in patients with severe acute pancreatitis compared to those with mild-to-moderate disease (pooled MD 3.59).
Loading...
Supports CRP/albumin ratio for early severity stratification in acute pancreatitis; extends meta-analytic evidence but leaves clinical impact open.
Meta-Analysis (n=2,244)
Does the CRP/albumin ratio at admission predict severity and mortality in patients with acute pancreatitis?
Mean Difference: 3.59 (95% CI 2.51–4.68)
p-value: p=<0.00001
A high CRP/albumin ratio at admission is a significant predictor of severity and mortality in patients with acute pancreatitis.
A 2024 study conducted a meta-analysis in Acute pancreatitis (n=2,244). Severe acute pancreatitis vs. Mild to moderate acute pancreatitis was evaluated on C-reactive protein-albumin (CRP/ALB) ratio at admission (MD 3.59, 95% CI 2.51-4.68, p=<0.00001). Upon admission, the C-reactive protein-to-albumin ratio was significantly higher in patients with severe acute pancreatitis compared to those with mild-to-moderate disease (pooled MD 3.59).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: